FDA — authorised 11 September 2009
- Marketing authorisation holder: THERAVANCE BIOPHARMA
- Status: approved
🇺🇸 Vibativ in United States
FDA authorised Vibativ on 11 September 2009
Marketing authorisations
FDA — authorised 11 September 2009
- Application: NDA022110
- Marketing authorisation holder: CUMBERLAND
- Local brand name: VIBATIV
- Indication: POWDER — INTRAVENOUS
- Status: approved
Vibativ in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Vibativ approved in United States?
Yes. FDA authorised it on 11 September 2009; FDA authorised it on 11 September 2009.
Who is the marketing authorisation holder for Vibativ in United States?
THERAVANCE BIOPHARMA holds the US marketing authorisation.